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Persistent DNAdamage induces profound alterations in gene
expression that, in turn, influence tissue homeostasis, tumori-
genesis, and cancer treatment outcome. However, the underly-
ing mechanism for gene expression reprogramming induced by
persistent DNA damage remains poorly understood. Here,
using a highly effective bioluminescence-based reporter system
and other tools, we report that persistent DNA damage inhibits
nonsense-mediated RNA decay (NMD), an RNA surveillance
and gene-regulatory pathway, in noncycling cells. NMD sup-
pression by persistent DNA damage required the activity of the
p38MAPK. Activating transcription factor 3 (ATF3), anNMD
target and a key stress-inducible transcription factor, was stabi-
lized in a p38- and NMD-dependent manner following persis-
tent DNA damage. Our results reveal a novel p38-dependent
pathway that regulates NMD activity in response to persistent
DNA damage, which, in turn, controls ATF3 expression in
affected cells.
The cellular response to persistent DNA damage influences
tissue homeostasis, tumorigenesis, and cancer progression
(1–3). Persistent DNA damage occurs when new damage is
constantly being introduced, for instance, by excessive mito-
genic signals or by cancer treatments such as chemotherapy or
radiation, or when DNA damage is difficult to repair (4–14).
Proliferating cells are particularly susceptible to persistent
DNA damage and usually undergo programmed cell death, as
carrying genetic lesions through cell division causes severe
genomic instability. However, nonproliferating cells can toler-
ate a certain dose of persistent DNA damage. In these non-
cycling cells, persistent DNA damage reprograms gene expres-
sion to promote responses such as cellular senescence,
characterized by exit from the cell cycle and profound changes
in morphology, signaling, and gene expression, and the senes-
cence-associated secretory phenotype (SASP),3 a collection of
secreted factors such as cytokines, chemokines, growth factors,
and proteases (1, 3, 15). Both senescence and SASP directly
impact the tumorigenesis process and cancer treatment out-
come by influencing tumor cell growth and modifying the
tumor microenvironment (2, 15–22). These phenotypes and
other responses to persistent DNA damage are a result of gene
expression reprogramming brought about by signaling mole-
cules such as p38, which regulate transcription, RNA stability,
and translation (17, 23). The p38 MAPK, which contains four
isoforms (p38, p38, p38, and p38), plays a key role in the
cellular response to persistent DNA damage as well as other
stresses (23). In certain contexts, where persistent DNA dam-
age is present, p38 can promote cellular senescence and SASP
expression (17, 24–31).
Originally identified as an RNA quality control pathway that
detects and degrades aberrant mRNAs with premature transla-
tion termination codons (PTCs), nonsense-mediated RNA
decay (NMD) has also emerged as a prominent gene-regulatory
mechanism (32, 33). NMD controls the stability of many nor-
mal transcripts that contain features recognizable to the NMD
machinery, such as upstreamORFs, 3UTR introns, alternative
splice variants that introduce a PTC, or exceedingly long 3
UTRs (33–35). By degrading transcripts bearing such NMD-
inducing features,NMDcontributes to gene expression profiles
crucial for development and other cellular processes (36–46).
In addition to “constitutively” degrading target mRNAs, NMD
also contributes to gene expression changes in response to
developmental and environmental cues that adjust NMD effi-
ciency. For instance,NMDactivity is repressed during neuronal
differentiation as well as myogenesis to enhance the expression
of NMD target transcripts that facilitate proper development
(36, 41). These alterations of NMD activity appear to be essen-
tial in vertebrates, as many NMD-deficient mutants exhibit
abnormal brain, eye, and cardiovascular development and are
lethal (47). NMD also helps coordinate the cellular response to
several forms of stress, including amino acid deprivation,
hypoxia, and endoplasmic reticulum stress, by governing the
expression levels of many stress response genes (39, 42, 44, 45,
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48). Furthermore, when cells are exposed to severe stresses that
cause apoptosis, NMD is attenuated as a result of proteolytic
cleavage of the core NMD factor UPF1, leading to the up-reg-
ulation of a number of apoptosis genes (49).
In this work, we investigated the potential regulation of
NMDbypersistentDNAdamage and its effects on gene expres-
sion. Using a highly effective reporter system, we found that
NMD activity is attenuated by persistent DNA damage in
nonproliferating cells, leading to stabilization and up-regu-
lation of the transcripts of ATF3, a known NMD target and a
key transcription factor that regulates gene expression, to
promote the establishment of senescence and SASP expres-
sion after DNA damage (39, 44, 50–53). The repression of
NMD by persistent DNA damage is mediated in part by
p38, although p38 activation alone is not sufficient to
inhibit NMD. Our results reveal a novel p38-dependent
pathway that regulates NMD activity in response to persis-
tent DNA damage and contributes to gene expression alter-
ations in non-cycling cells.
Results
Persistent DNA damage, but not transient DNA damage,
inhibits NMD
To determine whether persistent DNA damage modulates
NMD activity, we treated confluent nontransformed human
RPE1 cells with the DNA-damaging agent bleomycin (63
g/ml) for 24 h and then allowed the cells to recover in the
absence of bleomycin for 4 days. Subsequently, NMD activity
was assessed using a previously developed bioluminescent
NMD reporter system (Fig. 1a) (54). Using this reporter, NMD
is quantified by the ratio of red bioluminescence signal, pro-
duced by the CBR luciferase fused to a PTC-containing TCR
minigene (CBR-TCR(PTC)), to green bioluminescence signal,
produced by the CBG luciferase fused to a wild-type TCR
minigene (CBG-TCR(WT)). As expected, bleomycin generated
significant amounts of DNA damage and induced a robust
DDR that persisted at the time ofNMDanalysis, as indicated by
the phosphorylation of the histone variant H2AX (H2AX), a
widely used DDR marker (Fig. 1b). Strikingly, bleomycin-
treated cells exhibited an 2-fold increase in the CBR:CBG
ratio, indicative of NMD repression (Fig. 1c, left panel). This
bioluminescence imaging result was corroborated by real-time
qPCR analysis of the mRNA levels of the CBR-TCR(PTC) and
CBG-TCR(WT) reporters (Fig. 1c, right panel). Bleomycin-me-
diatedNMD suppression is not specific to RPE1 cells, as similar
results were obtained in confluent human BJ fibroblasts (Fig.
1d). Together, these data suggest that persistent DNA damage
represses NMD.
To further demonstrate that persistent DNA damage atten-
uates NMD activity, we used other methods to induce persis-
tent DNA damage and examined NMD efficiency using our
bioluminescent reporter. Continuous treatment of RPE1 cells
with a low concentration (60 nM) of the topoisomerase I inhib-
itor camptothecin (CPT) for 5 days also attenuatedNMDactiv-
ity (Fig. 1e). Similarly, exposing cells to high doses (10 Gy) of
ionizing radiation 6 days prior to NMD analysis resulted in
NMD repression (Fig. 1f ). In contrast, a 0.5-Gy dose of ionizing
radiation,which initially induced theDDR (data not shown) but
did not cause enough damage to persist for 6 days, did not affect
NMDactivity (Fig. 1f ). Taken together, these data strongly sug-
gest that NMD is inhibited in response to persistent DNAdam-
age in non-cycling human cells.
To distinguish between the effects of persistent DDRs and
immediate DDRs on NMD, we again treated RPE1 cells with
bleomycin for 24 h but assessed NMD activity immediately fol-
lowing the treatment. High levels of H2AX signal detected by
immunofluorescence staining and Western blotting indicated
that these conditions generate a strongDDR (Fig. 2a).However,
a similar level of NMD activity was detected in bleomycin-
treated and H2O-treated (control) cells, indicating that NMD
activity is not altered immediately after DNA damage (Fig. 2b).
This suggests that DNA damage signals do not immediately
influence NMD activity.
We next determined whether a low level of transient DNA
damage, which can be readily repaired, exerts a delayed effect
on NMD activity or whether DNA damage must persist to
induce NMD repression. To this end, RPE1 cells were treated
for 1 hwith the same dose of bleomycin as above and allowed to
recover for 3 h (to detect an immediate response) or 5 days (to
detect a delayed response). These conditions generated a robust
DNA damage response initially at the 4-h time point, but little
or no DNA damage persisted to day 5 (see the H2AX signal in
Fig. 2c). In this setting, no difference in NMD efficiency was
observed at either time point (Fig. 2c). Taken together, these
data indicate that persistent DNA damage, but not transient
DNA damage, induces NMD inhibition.
NMD repression is not a common feature of cellular
senescence
Persistent DNA damage induces cellular senescence, which
is accompanied by substantial changes in cellular morphology,
metabolism, and gene expression (15). It is possible that the
NMD attenuation caused by persistent DNA damage stems
from the establishment of a senescent state rather than directly
from DNA damage signaling. Results of senescence-associated
(SA) -gal staining indicates that our treatment conditions
used to generate persistent DNA damage efficiently induced
cellular senescence (Fig. 3a). To determinewhetherNMD inhi-
bition is a facet of the senescence phenotype, even in the
absence of DNA damage, we induced senescence by infecting
RPE1 cells with lentiviruses expressing the cell cycle inhibitor
p16 and then measured NMD activity using our biolumines-
cent reporter. Like bleomycin treatment, p16 overexpression
efficiently induced senescence (Fig. 3b). However, no DDR was
induced by p16 overexpression, as indicated by the lack of
H2AX signal in the cells (Fig. 3c). In contrast to cells with
persistent DNA damage, no significant changes in NMD activ-
ity were detected in p16-expressing senescent cells compared
with nonsenescent control cells expressing the empty vector
(Fig. 3c). These results suggest that NMD repression is not an
obligate consequence of cellular senescence; rather, NMD
activity is likely regulated directly by signals emanating from
persistent DNA lesions.
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Persistent DNA damage inhibits NMD in a p38-dependent
manner
The MAPK p38 is a key player in the cellular response
to persistent DNA damage (23). Consistent with previous
findings, bleomycin-treated RPE1 cells exhibited robust p38
activation and signaling, as evidenced by the increase in p38
phosphorylation at Thr-180/Tyr-182 and phosphorylation of
HSP27 at Ser-82, a downstream target of p38 (Fig. 4a) (17, 55).
To test the possibility that p38 mediates NMD suppression in
cells with persistent DNA damage, we depleted p38, a ubiqui-
tously expressed and major isoform of p38, in RPE1 cells using
a previously validated shRNA (Fig. 4b) (17, 56). p38 knock-
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down significantly restored NMD activity in the presence of
persistentDNAdamage, albeit partially (Fig. 4c). In further sup-
port of the role of p38 as a mediator of NMD suppression,
CDD111 (also known as SD0006), a p38-specific kinase inhib-
itor that prevents downstream p38 signaling but not phosphor-
ylation of p38 itself, partially restoredNMDactivity in the pres-
ence of persistent DNA damage (Fig. 4d) (57). Importantly,
disruption of p38 activity in the absence of DNA damage did
not significantly alter NMD activity (Fig. 4, c and d). These
results indicate that p38 is a novel regulator of NMD
in response to persistent DNA damage. In addition, the
requirement of p38 for NMD suppression further demon-
strates that the effects of persistent DNA damage on NMD
are not simply caused by an increase in the production of
mutant mRNAs in the damaged cells that may overwhelm
the NMD machinery.
Figure 1. Persistent DNAdamage inhibits NMD. a, schematic of a dual-color bioluminescence-based reporter formeasuring NMD activity in human cells. b,
left panel, representative images of immunofluorescence staining for DAPI or H2AX in RPE1 cells after 24-h treatment with either H2O or bleomycin (Bleo),
followed by 96-h recovery. Right panel, Western blot showing H2AX levels in lysates collected after 24-h treatmentwith either H2O or bleomycin, followed by
96-h recovery. c, left panel, ratios of CBR:CBGbioluminescence signals in RPE1 cells expressing theNMD reporter (hereafter referred to as RPE1 reporter cells for
simplicity) after 24-h treatmentwith eitherH2Oorbleomycin, followedby96-h recovery.Data represent themeanS.D. of four independent experiments. ***,
p  0.001 (paired t test). Right panel, ratios of CBR-TCR(PTC):CBG-TCR(WT) mRNA expression in RPE1 reporter cells after 24-h treatment with either H2O or
bleomycin, followed by 96-h recovery. Data represent the mean  S.D. of four independent experiments. **, p  0.01 (paired t test). d, ratios of CBR:CBG
bioluminescence signals (top panel) and H2AX levels (bottom panel) in BJ fibroblasts expressing the NMD reporter after 24-h treatment with either H2O
or bleomycin, followed by 96-h recovery. Data represent the mean S.D. of three independent experiments. **, p 0.01 (paired t test). e, ratios of CBR:CBG
bioluminescence signals (top panel) and H2AX levels (bottom panel) in RPE1 reporter cells after 120-h treatment with either DMSO or 60 nM CPT. Data
represent the mean S.D. of four independent experiments. **, p 0.01 (paired t test). f, ratios of CBR:CBG bioluminescence signals (top panel) and H2AX
levels (bottom panel) in RPE1 reporter cells 144 h after exposure to 0 Gy, 0.5 Gy, or 10 Gy of ionizing radiation (IR). Data represent the mean S.D. of three
independent experiments. *, p 0.05 (paired t test).
Figure 2. Transient DNAdamage does not affect NMD. a, left panel, representative images of immunofluorescence staining for DNA or H2AX in RPE1 cells
after 24-h treatment with either H2O or bleomycin (Bleo). Right panel, Western blot showing H2AX levels in lysates collected after 24-h treatment with either
H2O or bleomycin. b, ratios of CBR:CBG bioluminescence signals in RPE1 reporter cells after 24-h treatment with either H2O or bleomycin. Data represent the
mean S.D. of three independent experiments.NS,p0.05 (paired t test). c, left panel, ratios of CBR:CBGbioluminescence signals (top panel) andH2AX levels
(bottom panel) in RPE1 reporter cells after 1-h treatment with either H2O or bleomycin, followed by 3-h recovery. Data represent the mean  S.D. of three
independent experiments. NS, p 0.05 (paired t test). Right panel, ratios of CBR:CBG bioluminescence (top panel) and H2AX levels (bottom panel) signals in
RPE1 reporter cells after 1-h treatment with either H2O or bleomycin followed by 120-h recovery. Data represent the mean  S.D. of three independent
experiments. NS, p 0.05 (paired t test).
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p38 activation is not sufficient to inhibit NMD
It has been shown that p38 activation is sufficient to induce
certain aspects of the persistent DNAdamage response, such as
expression and maintenance of several SASP factors (17, 31).
To determine whether p38 activation is also sufficient to atten-
uate NMD, we expressed a constitutively active version of
MKK6(MKK6-CA), anupstreamkinase thatdirectlyphosphor-
ylates and activates p38 (including p38), in RPE1 cells and
then assessed NMD activity via reporter imaging. Cells were
infected with adenoviruses expressing either LacZ (control) or
MKK6-CA and incubated for 7 days to induce an extended
period of p38 activation that mimics the prolonged p38 activa-
tion in cells harboring persistent DNA damage. MKK6-CA
expression induced a level of p38 activation comparable with
that induced by bleomycin treatment; however, it failed to alter
NMD activity (Fig. 5, a–c). These data suggest that p38 activa-
tion alone is not sufficient to inhibit NMD and that a second
signal induced by persistent DNA damage is needed to work in
concert with p38 to suppress NMD.
ATF3mRNA is stabilized by persistent DNA damage in a
p38-dependentmanner
The stress-induced transcription factor ATF3 is an NMD
target and is up-regulated in cells in response to persistent
DNA damage (39, 44, 58). The observed inhibitory effects of
persistentDNAdamage onNMDactivity lead us to predict that
ATF3 (and likely many other NMD targets) will be stabilized
under this condition. To test whether this is the case for ATF3
mRNAs, we generated persistent DNA damage in RPE1 cells
with bleomycin and used real-time qPCR to determine what
percentage of mRNAs remain undegraded at different time
points after treatmentwith actinomycinD, which prevents new
RNA synthesis. Consistent with ATF3 mRNAs being targets of
NMD,ATF3 transcripts exhibited a dramatic increase in stabil-
ity and steady-state expression levels in bleomycin-treated
cells, which have low levels of NMD activity, compared with
H2O-treated cells, which have normal NMD activity (Fig. 6a).
No statistically significant stabilization was observed for ORCL
mRNA, which is not a NMD target, after bleomycin treatment
(Fig. 6a). Furthermore, we found that the elevated expression
and stabilization of ATF3 mRNAs in response to persistent
DNA damage are partially dependent on p38, whichmediates
NMD inhibition. Knockdown of p38 using an shRNA or inhi-
bition of p38 kinase activity using CDD111 partially reversed
the bleomycin-dependent stabilization (6 h after actinomycinD
treatment) and up-regulation of ATF3 transcripts (Fig. 6, b–d).
In contrast, ORCL mRNA remained unaffected by these treat-
ments (Fig. 6, b and d). These data suggest that p38 inhibits
ATF3mRNAdegradation, at least in part, throughNMDatten-
uation in response to persistent DNA damage, thereby aug-
menting its expression.
NMDattenuation by persistent DNA damage contributes to
the stabilization of ATF3 transcripts
To further demonstrate that NMD inhibition contributes to
ATF3mRNA stabilization in response to persistent DNA dam-
age, we knocked down the essential NMD factor SMG1 inRPE1
cells and assessed the stability of ATF3 transcripts after bleo-
mycin treatment. Consistent with ATF3 being an NMD target,
SMG1 knockdown stabilized ATF3 transcripts in the absence
of DNA damage (Fig. 6, e and f ). If NMD inhibition contributes
to ATF3 stabilization after persistent DNA damage, then one
would expect thatATF3 transcriptswill exhibit a similar level of
stability in control and SMG1 knockdown cells after bleomycin
treatment because NMD is also inhibited in control knock-
down cells with persistent DNAdamage. However, if persistent
DNA damage stabilizes ATF3 mRNA independently of NMD
inhibition, then SMG1 knockdown cells will show a higher level
of stability of ATF3 transcripts after persistentDNAdamage, as
the transcriptswill be stabilized both by attenuatedNMDactiv-
ity (because of SMG1 knockdown) and the NMD-independent
mechanism. The result shown in Fig. 6f indicates that SMG1
Figure 3. Although p16 overexpression, like persistent DNA damage,
can inducecellular senescence, itdoesnotalterNMDactivity.a, left panel,
representative SA-gal staining imagesof RPE1 reporter cells after 24-h treat-
ment with either H2O or bleomycin (Bleo), followed by 96-h recovery. Right
panel, percentage of SA -gal–positive RPE1 cells after 24-h treatment with
either H2O or bleomycin, followed by 96-h recovery. Data represent the
mean S.D. of three independent experiments. *, p 0.05 (paired t test). b,
left panel, representative images of RPE1 reporter cells expressing either
empty vector or p16 after SA -gal staining. Right panel, percentage of SA
-gal–positive RPE1 cells expressing either empty vector or p16. Data repre-
sent themean S.D. of three independent experiments. *, p 0.05 (paired t
test). c, top panel, ratios of CBR:CBG bioluminescence signals in RPE1 reporter
cells expressing either empty vector or p16. Data represent the mean S.D.
of three independent experiments. NS, p 0.05 (paired t test). Bottom panel,
Western blot showing H2AX levels in cells overexpressing either empty vec-
tor or p16.
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knockdown did not cause a further increase in ATF3 mRNA sta-
bility after bleomycin treatment compared with control knock-
down cells, reinforcing the idea thatNMD inhibition by persistent
DNAdamage contributes to the stabilization of ATF3 transcripts.
However, compared with the effects of SMG1 knockdown, bleo-
mycin treatment induced a higher level of stabilization of ATF3
mRNAs (Fig. 6f ), suggesting that additional mechanisms exist
to further stabilizeATF3 transcripts after persistentDNAdam-
age (see “Discussion”). Taken together, the data described
above strongly suggest that NMD attenuation contributes to
ATF3 up-regulation, via p38 activation, in response to persis-
tent DNA damage (Fig. 6g).
Discussion
In this study, we found that persistent DNA damage, but not
transient DNA damage, induces NMD repression and that this
repression contributes to the stabilization of the mRNA of the
transcription factor ATF3. In addition, we found that the inhi-
bition of NMD by persistent DNA damage requires p38
MAPK but is independent of cellular senescence.
Our finding of NMD regulation by persistent DNA damage
expands our understanding of the persistent DNA damage
response and the physiological role of the NMD pathway. In
addition to degrading mutant nonsense mRNAs, NMD con-
trols the expression of many normal transcripts. By demon-
strating the suppression of NMD activity in the presence of
persistent DNA damage, we illuminate another mechanism for
the reprogramming of gene expression in the persistent DNA
damage response. Our results strongly suggest that persistent
DNA damage reduces NMD activity toward ATF3 transcripts,
thereby increasing their stability. As a transcription factor,
Figure 4. NMD inhibition by persistent DNAdamage ismediated in part by p38. a, levels of total p38 and phosphorylated p38 andHSP27 in RPE1 cells
treated with either H2O or bleomycin (Bleo) for 24 h, followed by 96-h recovery. b, shRNA-mediated knockdown of p38 in RPE1 cells. c, ratios of CBR:CBG
bioluminescence signals in control and p38 knockdown RPE1 reporter cells after 24-h treatment with either H2O or bleomycin, followed by 96-h recovery.
Data represent the mean  S.D. of four independent experiments. **, p  0.01 (paired t test). d, ratios of CBR:CBG bioluminescence signals in DMSO- or
CDD111-treated RPE1 reporter cells after 24-h treatment with either H2O or bleomycin, followed by 96-h recovery. Data represent the mean S.D. of three
independent experiments. *, p 0.5; **, p 0.01 (paired t test).
Figure 5. p38 activation is not sufficient to inhibit NMD. a, levels of MKK6, both total p38 and phosphorylated p38 and HSP27 in RPE1 cells expressing LacZ or
constitutively activeMKK6-CA for 7days.b, comparisonof the levels of total p38 andphosphorylatedp38 in RPE1 cells overexpressing either LacZorMKK6-CA for 7
dayswith that inRPEcells treatedwitheitherH2Oorbleomycin (Bleo) for24h, followedby96-h recovery.c, ratiosofCBR:CBGbioluminescencesignals inRPE1reporter
cells expressing either LacZ orMKK6-CA for 7 days. Data represent themean S.D. of three independent experiments.NS, p 0.05 (paired t test).
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ATF3 regulates the cellular responses to multiple forms of
stress, including DNA damage, by controlling the expression of
many genes (59). Thus, the up-regulation of ATF3 caused by
NMD inhibition is expected to contribute to expression
changes for many other genes in response to persistent DNA
damage, which may directly promote the survival and adapta-
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tion of damaged cells. This regulation of NMD and ATF3 by
persistent DNA damage may also have important relevance to
tumorigenesis and cancer treatment. The mainstays of cancer
treatment are radiation and chemotherapy, both of which gen-
erate DNA damage. However, the efficacy of DNA-damaging
therapies is hampered by frequent cancer relapse, which is in
part caused by the remodeling of the tumormicroenvironment
following treatment (16, 18, 20, 60). The gene expression
changes in non-cycling stromal cells caused by therapy-in-
duced persistent DNA damage promote cellular senescence
and the SASP, both of which play a crucial role in shaping the
tumor microenvironment (2, 60). Stabilization of ATF3 tran-
scripts because of NMD attenuation under this condition may
promote expression of SASP factors that are target genes of
ATF3 (50). A number of key SASP factors, such as IL-6 and
CXCL2, have been suggested to be direct targets ofNMD (2, 44,
45). Given that many of these SASP factors are pro-tumori-
genic, restoring NMD activity in stromal cells in the tumor
microenvironment could be beneficial during cancer treatment
(15).
Our study has also identified a novel role for p38 in regulat-
ing NMD activity. As a key player in the persistent DNA dam-
age response, p38 controls senescence induction and SASP
expression in part by regulating gene expression (23, 61, 62).
p38 induces gene expression changes by altering the activities
of transcription factors and RNA binding proteins to regulate
transcription, mRNA stability, and translation (23). The sup-
pression of NMD by p38 identified in this study is a new p38-
mediated mechanism to regulate mRNA stability (Figs. 4 and
6). In addition toNMD, p38 also controls the stability ofmany
mRNAs after persistent DNA damage by reducing the occu-
pancy of the RNA-binding protein AUF1 on their 3 UTR,
which normally promotes their degradation (17). Interestingly,
it has been shown that AUF1 also binds to the 3UTR of ATF3
mRNA and that this AUF1 binding is reduced in response to
amino acid deprivation, leading to stabilization of ATF3 tran-
scripts (63). It will be interesting to determine whether the
p38–AUF1 axis also plays a role inATF3mRNAstabilization in
the persistent DNAdamage response. The combined effects on
transcriptional activation and mRNA stabilization of ATF3
mRNA lead to up-regulation of ATF3 and downstream gene
expression alterations after persistent DNA damage. Although
p38 is required for NMD attenuation after persistent DNA
damage, p38 activation alone is not sufficient to suppress
NMD (Fig. 5). Presumably, p38 functions in concert with
another signal generated by persistent DNA damage to control
NMD activity. Further dissection of the mechanism of NMD
regulation by p38 and other factors will provide crucial
insights into the reprogramming of gene expression in the per-
sistent DNA damage response, which is directly relevant to the
understanding and treatment of cancer.
Experimental procedures
Cell culture, adenovirus and lentivirus production, and
infection
RPE1 cells weremaintained inDMEMnutrientmixture F-12
Ham (Sigma, D6421) supplemented with 100 units/ml penicil-
lin, 100g/ml streptomycin, 2.5mM L-glutamine, and 7.5% FBS
and grown in a 5% CO2 incubator at 37 °C. Human foreskin BJ
fibroblasts were maintained in 70% DMEM (Sigma, D5796),
15% medium 199 (Sigma, M7528), and 15% FBS supplemented
with 100 units/ml penicillin and 100 g/ml streptomycin and
grown in a 5% CO2 incubator at 37 °C. Human HEK293T and
HEK293 cells were cultured in DMEM (Sigma, D5796) with
10% FBS at 37 °C with 5% CO2.
An adenoviral construct encoding the bioluminescent NMD
reporter was generated by inserting the reporter into the pAd-
enoX-PRLS-ZsGreen1 vector using the In-Fusion HD cloning
kit (Clontech) according to the protocol of themanufacturer. A
linearized adenoviral vector with exposed inverted terminal
repeats was transfected into HEK293 cells for viral production,
followed by viral amplification in the same cell line. Target cells
were infected with adenoviruses for 24 h before biolumines-
cence imaging.
To knock down p38 or SMG1 in RPE1 cells, lentiviruses
expressing a non-targeting control shRNA (5-CAACAAGA-
UGAAGAGCACCAA-3), an shRNA targeting p38 (5-
GUUACGUGUGGCAGUGAAGAA-3), or an shRNA target-
ing SMG1 (5-GCCGAGAUGUUG AUCCGAAUA-3) were
generated in HEK293T cells as described previously (54).
Briefly, HEK293T cells were co-transfected with an shRNA-
encoding lentiviral vector and packaging plasmids (pCMV-
dR8.2 and pCMV-VSVG) using TransIT-LT1 transfection re-
Figure 6. NMD suppression by p38 in response to persistent DNA damage contributes to ATF3mRNA stabilization. a, left panel, percentage of ATF3
andORCLmRNAs remaining in RPE1 reporter cells after 24-h treatmentwith either H2O or bleomycin (Bleo), followed by 96-h recovery. Following the recovery
period, actinomycinDwas added, and total RNAwas collected at the indicated times, followedby quantitative RT-PCR analysis. The difference in ATF3 stability
between H2O- or bleomycin-treated cells is statistically significant (p 0.01, paired t test) for each time point. No significant stabilization of ORCL mRNA was
observedbetweenH2O- or bleomycin-treated cells. Data represent themean S.D. of three independent experiments.Right panel, steady-state levels of ATF3
transcripts in RPE1 reporter cells after 24-h treatment with either H2O or bleomycin, followed by 96-h recovery. Expression in the H2O-treated cells was
normalized to 1. Data represent the mean S.D. of five independent experiments. ***, p 0.001 (paired t test). b, left panel, percentage of ATF3 and ORCL
mRNAs remaining in DMSO- and CDD111-treated RPE1 reporter cells after 24-h treatment with either H2O or bleomycin, followed by 96-h recovery and then
actinomycinD treatment for 6 h. Sampleswere collected immediately before or after 6-h treatmentwith actinomycinD.Right panel, steady-state levels of ATF3
transcripts in DMSO- and CDD111-treated RPE1 cells after 24-h treatment with either H2O or bleomycin, followed by 96-h recovery. Expression in the H2O-
treated cells was normalized to 1. Data represent the mean S.D. of five independent experiments. **, p 0.01; ***, p 0.001 (paired t test). NS, p 0.05. c,
shRNA-mediatedknockdownofp38 in RPE1cells.d, left panel, percentageofATF3andORCLmRNAs remaining in control andp38 knockdownRPE1 reporter
cells after 24-h treatment with either H2O or bleomycin, followed by 96-h recovery. Samples were collected as in b. Right panel, steady-state levels of ATF3
transcripts in control and p38 knockdown-treated RPE1 reporter cells after 24-h treatment with either H2O or bleomycin, followed by 96-h recovery.
Expression in theH2O-treated cellswasnormalized to1.Data represent themeanS.D. of four independent experiments. *,p0.05; **,p0.01 (paired t test).
NS, p 0.05. e, shRNA-mediated knockdown of SMG1 in RPE1 cells. f, percentage of ATF3 andORCLmRNAs remaining in control- and SMG1 knockdown RPE1
cells that were treatedwith either H2O or bleomycin for 24 h, followed by 96-h recovery. Actinomycin Dwas added to cells to suppress transcription, and total
RNAwas collected immediately before or 6 h after addition of actinomycinD, followed by quantitative RT-PCR analysis. Data represent themean S.D. of four
independent experiments. *, p 0.05; NS, p 0.05 (paired t test). g, model for the regulation of NMD activity by p38 in response to persistent DNA damage
that leads to the stabilization of ATF3 mRNAs and subsequent changes in transcription and gene expression.
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agent (Mirus). Virus-containing supernatant was collected 48
and 72 h after transfection. Filtered viruses were used to infect
RPE1 cells, followed by puromycin selection.
To generate recombinant retroviruses expressing the CDK
inhibitor p16, HEK293T cells were co-transfected with either
pBabe-puro or pBabe-puro-p16 and packaging plasmids (pCMV-
UMVC and pCMV-VSVG) using TransIT-LT1 transfection re-
agent. Virus-containing supernatant was collected 48 and 72 h
after transfection. RPE1 cells were then infected with the
viruses, followed by puromycin selection.
For the MKK6 experiments, RPE1 cells were plated at a den-
sity of 150,000 cells/well in a 6-well plate and allowed to grow
for 48hbefore addition of either LacZorMKK6-CAadenovirus
(gifts from Dr. Tatiana Efimova) at 1:1000 dilution. The virus
was removed after 24 h, and cells were allowed to recover for 6
days before NMD analysis.
Cell plating conditions and induction of persistent DNA
damage
Bleomycin treatment—For all 24-h bleomycin treatments,
RPE1 cells or BJ fibroblast cells were plated at a density of
150,000 cells/well in 6-well plates and allowed to grow to con-
fluency for 72 h before addition of bleomycin. For 1-h bleomy-
cin treatments, cells were plated at a density of 100,000 cells/
well in 6-well plates and allowed to grow for 48 h before
beginning treatment. Bleomycin (B8416, Sigma) was dissolved
in water at 15 units/ml (9.4 mg/ml) and diluted in medium
1:149.25 to a final concentration of 63 g/ml for treatment.
CDD111 (10 mM stock solutions in DMSO) was diluted 1:1000
in medium to a final concentration of 10 M for treatment.
Medium containing DMSO or CDD111 was refreshed daily.
CPT treatment—RPE1 cells were plated at a density of 50,000
cells/well in 6-well plates and cultured for 72 h before beginning
treatment. CPT (60 M in DMSO) was diluted 1:1000 in
medium to a final concentration of 60 nM for treatment.
Medium containing DMSO or CPT was refreshed daily.
Irradiation—RPE1 cells were plated at a density of 150,000
cells/well in 6-well plates and allowed to grow to confluency for
72 h before irradiation. Cells were irradiated with doses of
either 0.5 Gy or 10 Gy at 0.625 Gy/min using a Gammacell 40
irradiator.
Reporter adenoviral transduction—For NMD analysis, the
NMD reporter was introduced into cells via adenoviral infec-
tion.Adenoviruses expressing theNMDreporterwere added to
cell growth medium 24 h prior to bioluminescence imaging.
Bioluminescence imaging and spectral deconvolution for
signal unmixing
Cells were incubated with 150 g/ml D-luciferin for 10 min
at 37 °C, and bioluminescence signals were measured using a
charge-coupled device camera-based bioluminescence imaging
system (IVIS 50, Caliper) with appropriate open, red, or green
filters and exposure settings (exposure time: 30 s, 60 s, 60 s;
binning: 8; field of view: 15; f/stop: 1). Regions of interest were
drawn over images of wells, and bioluminescence signals were
quantified using the Living Image (Caliper) and Igor (Wavem-
etrics) analysis software packages as described previously (54,
64). Spectral unmixing was performed using a previously devel-
oped ImageJ plugin as described previously (54, 64). Detailed
original results are available upon request.
Reverse transcription, qPCR, andWestern blotting
Total RNA was isolated using the NucleoSpin RNA kit from
Clontech (740955), and cDNA was synthesized using the Pri-
meScript RT reagent kit from Clontech (RR037A) according to
the instructions of themanufacturer. qPCR reactions were per-
formed in triplicate using a two-step PCR protocol (melting
temperature, 95 °C; annealing and extension temperature,
60 °C; cycle number, 40) on an ABI VII7 real-time PCR system
with PowerUp SYBR Green Master Mix (Thermo Scientific).
ThemRNA levels of the housekeeping gene GAPDHwere used
for normalization. Primers for ATF3 (forward, 5-GCCATTG-
GAGAGCTGTCTTC-3; reverse, 5-GGGCCATCTGGAAC-
ATAAGA-3), ORCL (forward, 5-GGCAGCAGATGAAAT-
CTGAA-3; reverse, 5-TCCAGAATGTGATTTTTGCAG-
3), and GAPDH (forward, 5-AACAGCCTCAAGATC-
ATCAGC-3; reverse, 5-GATGATGTTCTGGAGAGCC-3)
were purchased from Integrated DNA Technologies. Detailed
original results are available upon request.
Western blotting was performed using the Li-Cor Odyssey
system. Briefly, cells were lysed with SDS sample buffer (90 mM
Tris, 20% glycerol, 2% SDS, and 5% -mercaptoethanol). Sam-
ples were run on SDS-PAGE gel and transferred to a PDVF
membrane. Membranes were blocked in casein buffer and sub-
sequently probed with primary antibody diluted in casein
buffer. Antibodies against H2AX (9718, 1:1000), p38 (9218,
1:1000), phospho-p38 (4511, 1:1000), HSP27 (2402, 1:1500),
phospho-HSP27 (9709, 1:1000), MKK6 (9264, 1:1000), and
SMG1 (9149, 1:1000) were purchased from Cell Signaling
Technology. Ku70 (MMS-263R) and -Actin (MA5-15739,
1:5000) antibodies were purchased fromThermo Scientific and
Covance, respectively.
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